Medetomidine Hydrochloride

58 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

690.0%

Death Rate

Active Ingredients

Medetomidine Hydrochloride

Administration Routes

UnknownIntramuscularIntravenousParenteralIntra-ArterialOphthalmic

Species Affected

Dog 31

Cat 25

Human 1

Rabbit 1

Most Affected Breeds

Domestic Shorthair 8

Retriever - Labrador 4

Cat (unknown) 3

Dog (unknown) 3

Crossbred Canine/dog 2

Shepherd Dog - German 2

Abyssinian cat 2

Unknown 2

Pug 2

Pit Bull 2

Most Reported Reactions

Tachycardia 7

Lethargy (see also Central nervous system depression in 'Neurological') 6

Cardiac arrest 6

Hyperthermia 6

Blindness 5

Vomiting 4

Fever 4

Injection site swelling 4

Diarrhoea 4

Reddening of the skin 4

Tachypnoea 4

Lack of efficacy - NOS 3

Outcome Breakdown

Recovered/Normal

31 (53.4%)

Outcome Unknown

12 (20.7%)

Ongoing

10 (17.2%)

Died

4 (6.9%)

Recovered with Sequela

1 (1.7%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.